Plasma pentraxin 3 concentration increases in endurance-trained men

Medicine and Science in Sports and Exercise

Volumn 43, Issue 1, 2011, Pages 12-17

  Miyaki, Asako ^a   Maeda, Seiji ^a   Otsuki, Takeshi ^b   Ajisaka, Ryuichi ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b RYUTSU KEIZAI UNIVERSITY   (Japan)

Author keywords

Cardioprotection; Endurance training; HDL cholesterol; Systemic arterial compliance

Indexed keywords

C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PENTRAXIN 3; SERUM AMYLOID P;

ADULT; ARTICLE; BLOOD; CAROTID ARTERY; COMPLIANCE (PHYSICAL); CROSS-SECTIONAL STUDY; ECHOGRAPHY; ENDURANCE; EXERCISE; HUMAN; MALE; METABOLISM; OXYGEN CONSUMPTION; PHYSIOLOGY; SEDENTARY LIFESTYLE;

ADULT; C-REACTIVE PROTEIN; CAROTID ARTERIES; CHOLESTEROL, HDL; COMPLIANCE; CROSS-SECTIONAL STUDIES; EXERCISE; HUMANS; MALE; OXYGEN CONSUMPTION; PHYSICAL ENDURANCE; SEDENTARY LIFESTYLE; SERUM AMYLOID P-COMPONENT; YOUNG ADULT;

EID: 78650852917     PISSN: 01959131     EISSN: 15300315     Source Type: Journal    
DOI: 10.1249/MSS.0b013e3181e84bce     Document Type: Article

References (31)

1. Allain CC, Poon LS, Chan CS, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem. 1974;20: 470-5.
2. Baker TT, Allen D, Lei KY, Wilcox KK. Alterations in lipid and protein profiles of plasma lipoproteins in middle-aged men consequent to an aerobic exercise program. Metabolism. 1986;35: 1037-43.
3. Baum M, Klopping-Menke K, Müller-Steinhardt M, Liesen H, Kirchner H. Increased concentrations of interleukin 1-beta in whole blood cultures supernatants after 12 weeks of moderate endurance exercise. Eur J Appl Physiol. 1999;79:500-3.
4. Breviario F, d'Aniello EM, Golay J, et al. Interleukin-1-inducible genes in endothelial cells. Cloning of a new gene related to Creactive protein and serum amyloid P component. J Biol Chem. 1992;267:22190-7.
5. Cameron JD, Dart AM. Exercise training increases total systemic arterial compliance in humans. Am J Physiol. 1994;266: H693-701.
6. Cameron JD, Rajkumar C, Kingwell BA, Jennings GL, Dart AM. Higher systemic arterial compliance is associated with greater exercise time and lower blood pressure in a young older population. J Am Geriatr Soc. 1999;47:653-6.
7. Carnethon MR, Gurati M, Greenland P. Prevalence and cardiovascular disease correlates of low cardiorespiratory fitness in adolescents and adults. JAMA. 2005;294:2981-8.
8. Doni A, Michela M, Bottazzi B, et al. Regulation of PTX3, a key component of humoral innate immunity in human dendric cells: stimulation by IL-10 and inhibition by IFN-gamma. J Leukoc Biol. 2006;79:797-802.
9. Finley PR, Schifman RB, Williams RJ, Lichti DA. Cholesterol in high-density lipoprotein: use of Mg2+/dextran sulfate in its enzymatic measurement. Clin Chem. 1978;24:931-3.
10. Gomez-Merino D, Drogou C, Guezennec CY, Chennaoui M. Effects of chronic exercise on cytokine production in white adipose tissue and skeletal muscle of rats. Cytokine. 2007;40: 23-9.
11. Inoue K, Sugiyama A, Reid PC, et al. Establishment of a high sensitivity plasma assay for human pentraxin3 as a marker for unstable angina pectoris. Arterioscler Thromb Vasc Biol. 2007;27: 161-7.
12. Ito Y, Nomura S, Ueda H, et al. Exercise training increases membrane bound form of tumor necrosis factor-alpha receptors with decreases in the secretion of soluble forms of receptors in rat adipocyte. Life Sci. 2002;71:601-9.
13. Kohlmeler M. Direct enzymic measurement of glycerides in serum and in lipoprotein fractions. Clin Chem. 1986;32:63-6.
14. Lee GW, Lee TH, Vilcek J. TSG-14, a tumor necrosis factor- and IL-1-inducible protein, is a novel member of the pentraxin family of acute phase proteins. J Immunol. 1993;150:1804-12.
15. Mora S, Cook N, Buring JE, Ridker PM, Lee IM. Physical activity and reduced risk of cardiovascular events. Circulation. 2007;116: 2110-6.
16. Myers J, Prakash M, Froelicher V, Do D, Partington S, Atwood JE. Exercise capacity and mortality among men referred for exercise testing. N Engl J Med. 2002;346:793-801. (Pubitemid 34987553)
17. Napoleone E, Di Santo A, Peri G, et al. The long pentraxin PTX3 up-regulates tissue factor in activated monocytes: another link between inflammation and clotting activation. J Leukoc Biol. 2004;76:203-9.
18. Nara M, Kanda T, Tsukui S, et al. Running exercise increases tumor necrosis factor-a secreting from mesenteric fat in insulin- RESKL4NT rats. Life Sci. 1999;65:237-44.
19. Norata GD, Marchesi P, Pulakazhi Venu VK, et al. Deficiency of the long pentraxin PTX3 promotes vascular inflammation and atherosclerosis. Circulation. 2009;120:699-708.
20. O'Connell BJ, Genest J. High-density lipoproteins and endothelial function. Circulation. 2001;104:1978-83.
21. Ortega-Hernandez O, Bassi N, Shoenfield Y, Anaya JM. The long pentraxin 3 and its role in autoimmunity. Semin Arthritis Rheum. 2009;39:38-54.
22. Otsuki T, Maeda S, Lemitsu M, et al. Vascular endotheliumderived factors and arterial stiffness in strength- and endurancetrained men. Am J Physiol. 2007;292:H786-91.
23. Peri G, Introna M, Corradi D, et al. PTX3, a prototypical long pentraxin, is an early indicator of acute myocardial infarction in humans. Circulation. 2000;102:636-41.
24. Rolph MS, Zimmer S, Bottazzi B, Garlanda C, Mantovani A, Hansson GK. Production of the long pentraxin PTX3 in advanced atherosclerotic plaques. Arterioscler Thromb Vasc Biol. 2002;22: e10-4.
25. Salio M, Chimenti S, Angelis ND, et al. Cardioprotective function of the long pentraxin PTX3 in acute myocardial infarction. Circulation. 2008;117:1055-64.
26. Slein MW. D-Glucose: determination with hexokinase and glucose-6-phosphate dehydrogenase. In: Bergmeyer HU, editor. Methods of Enzymatic Analysis. New York: Academic Press; 1963. p. 117.
27. Suzuki S, Takeishi Y, Niizeki T, et al. Pentraxin 3, a new marker for vascular inflammation, predicts adverse clinical outcomes in patients with heart failure. Am Heart J. 2008;155:75-81.
28. Tang PC, Qin L, Zielonka J, et al. MyD88-dependent, superoxideinitiated inflammation is necessary for flow-mediated inward remodeling of conduit arteries. J Exp Med. 2008;205:3159-71.
29. Terenzi TJ. An alteration in arterial compliance associated with elevated aerobic fitness. J Manipulat Physiol Ther. 2000;23: 27-31.
30. Thompson PD, Cullinane EM, Sady SP, Flynn MM, Chenevert CB, Herbert PN.High-density lipoprotein metabolism in endurance athletes and sedentary men. Circulation. 1991;84:140-52.
31. Yamashita Y, Nakamura M, Koizumi H, et al. Evaluation of a homogeneous assay for measuring LDL-cholesterol in hyperlipidemic serum specimens. J Atheroscler Thromb. 2008;15:82-6.